FDA Authorizes Regeneron Monoclonal Antibodies for COVID-19
(CNN)The US Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron’s antibody cocktail to treat Covid-19 in high-risk patients with mild to moderate disease.
READ MORE

WHO recommends against the use of remdesivir in COVID-19 patients
WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients.
Read More

Mouthwash eliminates coronavirus in 30 seconds… in the lab
Mouthwash can eradicate coronavirus within 30 seconds of being exposed to it in a laboratory, a scientific study has found.

The preliminary result comes ahead of a clinical trial into whether using over-the-counter mouthwash has the potential to reduce the levels of COVID-19 in a patient’s saliva.
Read More

Tuberculosis Vaccine Could Play Role in COVID-19 Prevention
A group of researchers at Cedars-Sinai Medical Center in Los Angeles have found evidence that a tuberculosis vaccine has been associated with a reduced likelihood of contracting coronavirus disease 2019 (COVID-19). The research also found that the vaccine could help in reducing the level of severity of the disease.
READ MORE

‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die
Dr. Megan Ranney has learned a lot about COVID-19 since she began treating patients with the disease in the emergency department in February.

But there’s one question she still can’t answer: What makes some patients so much sicker than others?
Read More

Melatonin a Promising Candidate for Prevention and Treatment of COVID-19
As COVID-19 continues to spread throughout the world, particularly with cases rising during what some have termed the “fall surge,” repurposing drugs already approved by the U.S. Food and Drug Administration for new therapeutic purposes continues to be the most efficient and cost-effective approach to treat or prevent the disease.
Read More

As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts
Studies show women are four times more likely to experience long-term COVID symptoms, lasting weeks or months, including fatigue, weakness and a kind of mental confusion known as “brain fog,” 

As women, “maybe we survive it and are less likely to die, but then we have all these long-term complications,” Klein noted.
Read More